Pharvaris N.V.

PHVS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$32.25-1.13%

2026-08-03

Valuation Metrics

Pharvaris N.V.'s Market Cap is $2.25B. At end of 2025 it was $935M. Ranked #1970 of 3,112 in US market (top 63%), #742 of 1,445 on NASDAQ (top 51%), #123 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 46%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$2.25B	US#1,970/3,112 Sec#123/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-192M	US—/3,112 Sec—/269
Total Assets	$305M	US#2,891/3,112 Sec#209/269
Net Assets	$278M	US#2,591/3,112 Sec#168/269
Value
P/B	8.12x	US#2,503/3,112 Sec#190/269
FCF Yield	-7.46%	US—/3,112 Sec—/269
Profitability
ROE	-69.11%	US#2,800/3,112 Sec#199/269
ROA	-62.87%	US#3,008/3,112 Sec#241/269
Financial Health
Debt Ratio	9.92%	US#106/3,112 Sec#46/269
Total Debt	$867894.00	US#2,935/3,112 Sec#247/269
FCF	$-168M	US#2,700/3,112 Sec#199/269
Cash	$290M	US#1,453/3,112 Sec#83/269
Current Ratio	11.24x	US#218/3,112 Sec#70/269
Performance
1Y Return	61.25%	US#723/3,112 Sec#116/269
1M Return	-4.75%	US#2,215/3,112 Sec#124/269
From 52W High	-11.89%	US#1,181/3,112 Sec#67/269
1Y MDD	-19.90%	US#674/3,112 Sec#22/269
Trading
Volume	250,699 shares	US#2,523/3,112 Sec#243/269
Trading Value	$8M	US#2,455/3,112 Sec#197/269
Per Share
EPS	$-3.21	US—/3,112 Sec—/269
BPS	$4.96	US#2,231/3,112 Sec#133/269